Wyeth Pharmaceuticals has filed a claim to seek USD 960 million in damages from Sun Pharmaceuticals for alleged patent infringement in launching a generic version of Protonix in the United States. However, Sun Pharma disagrees with this claim and finds it unjustified.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!